Uterine Arteriovenous Malformations: Primary Treatment with Therapeutic Embolization

Robert L Vogelzang*, Albert A Nemcek Jr, Zeke Skrtic, Jan Gorrell, John Robert Lurain III

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

91 Scopus citations


Uterine arteriovenous malformations are rare lesions that can cause massive vaginal bleeding and spontaneous abortions. The majority are either congenital or related to gestational trophoblastic disease. Hysterectomy has been the treatment of choice. The authors successfully treated four patients with symptomatic uterine arteriovenous malformations by means of transcatheter embolization; three of the lesions were related to gestational trophoblastic disease and one was congenital. All were supplied by the uterine arteries that were subselectively embolized with particulate material. This resulted in prompt cessation of uterine hemorrhage. There were no complications, and one pregnancy was achieved. The three other women have normal menstruation and no recurrence of bleeding at follow-up 10–48 months after treatment. On the basis of this experience and that of others, embolotherapy should be the treatment of first choice in these lesions, as it appears safe and effective. Additionally, uterine function is preserved in patients who are usually reproductively active.

Original languageEnglish (US)
Pages (from-to)517-522
Number of pages6
JournalJournal of Vascular and Interventional Radiology
Issue number4
StatePublished - Jan 1 1991


  • Arteries, therapeutic blockade, 969.1299
  • Arteriovenous malformations, pelvic, 969.14, 969.715
  • Arteriovenous malformations, uterine, 969.14, 969.716
  • Uterus, hemorrhage, 854.319, 969.716

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Uterine Arteriovenous Malformations: Primary Treatment with Therapeutic Embolization'. Together they form a unique fingerprint.

Cite this